Dr. Vibha Yadav

Research Scientist
Tulane National Primate Research Center, USA

Highest Degree
Ph.D. in Biotechnology from Tulane National Primate Research Center, USA

My URL
https://livedna.org/91.6655

Share this Profile

Biography

Dr. Vibha Yadav is currently working as Tulane National Primate Research Center, USA. She obtained her PhD in Biotechnology from same Institute. Her main area of interest related to Pharmacology and Toxicology, Biomedical Sciences, and Molecular Sciences. Her area of expertise includes Virology, Infection Biology, SiRNA Screening, Bunyaviruses, Drug Screening, and Host Pathogen Interaction. She has published 16 research articles in journals contributed as author/co-author.

Area of Interest:

Pharmacology and Toxicology
Virology
Infection Biology
Immunology
Microbiology

Selected Publications

  1. Kumar, M., D.P. Bhadoria, K. Dutta, S. Singh and J. Gupta et al., 2011. Combinatorial effect of TIMP-1 and α1AT gene polymorphisms on development of chronic obstructive pulmonary disease. Clin. Biochem., 44: 1067-1073.
    CrossRef  |  PubMed  |  Direct Link  |  

  2. Chhillar, A.K., V. Yadav, A. Kumar, M. Kumar and V.S. Parmar et al., 2009. Differential expression of Aspergillus fumigatus protein in response to treatment with a novel antifungal compound, diethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarboxylate. Mycoses, 52: 223-227.
    CrossRef  |  PubMed  |  Direct Link  |  

  3. Prasad, A.K., P. Kumar, A. Dhawan, A.K. Chhillar and D. Sharma et al., 2008. Synthesis and antimicrobial activity of 3-arylamino-1-chloropropan-2-ols. Bioorg. Med. Chem. Lett., 18: 2156-2161.
    CrossRef  |  PubMed  |  Direct Link  |  

  4. Yadav, V., R. Mandhan, Q. Pasha, S. Pasha and A. Katyal et al., 2007. An antifungal protein from Escherichia coli. J. Med. Microbiol., 56: 637-644.
    CrossRef  |  

  5. Gupta, J., D. Chattopadhaya, D.P. Bhadoria, M.A.Q. Pasha and V.K. Gupta et al., 2007. T lymphocyte subset profile and serum alpha-1-antitrypsin in pathogenesis of chronic obstructive pulmonary disease. Clin. Exp. Immunol., 149: 463-469.
    CrossRef  |  PubMed  |  Direct Link  |  

  6. Tiwari, R.K., D. Singh, J. Singh, V. Yadav and A.K. Pathak et al., 2006. Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles. Bioorg. Med. Chem. Lett., 16: 413-416.
    CrossRef  |  PubMed  |  Direct Link  |  

  7. Tiwari, R.K., A.K. Verma, A.K. Chhillar, D. Singh and J. Singh et al., 2006. Synthesis and antifungal activity of substituted-10-methyl-1,2,3,4-tetrahydropyrazino[1,2-a]indoles. Bioorg. Med. Chem., 14: 2747-2752.
    Direct Link  |  

  8. Chhillar, A.K., P. Arya, C. Mukherjee, P. Kumar and Y. Yadav et al., 2006. Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: Novel compounds against aspergillosis. Bioorg. Med. Chem., 14: 973-981.
    CrossRef  |  PubMed  |  Direct Link  |  

  9. Chaudhary, P., R. Kumar, A.K. Verma, D. Singh and V. Yadav et al., 2006. Synthesis and antimicrobial activity of N-alkyl and N-aryl piperazine derivatives. Bioorg. Med. Chem., 14: 1819-1826.
    CrossRef  |  PubMed  |  Direct Link  |  

  10. Yadav, V., R. Mandhan, R. Dabur, A.K. Chhillar and J. Gupta et al., 2005. A fraction from Escherichia coli with anti-Aspergillus properties. J. Med. Microbiol., 54: 375-379.
    CrossRef  |  PubMed  |  Direct Link  |  

  11. Yadav, V., J. Gupta, R. Mandhan, A.K. Chhillar and R. Dabur et al., 2005. Investigations on anti-Aspergillus properties of bacterial products. Lett. Appl. Microbiol., 41: 309-314.
    CrossRef  |  PubMed  |  Direct Link  |  

  12. Kashyap, M.K., V. Yadav, B.S. Sherawat, S. Jain and S. Kumari et al., 2005. Different antioxidants status, total antioxidant power and free radicals in essential hypertension. Mol. Cell Biochem., 277: 89-99.
    CrossRef  |  Direct Link  |  

  13. Gupta, J., D.P. Bhadoria, M.K. Lal, R. Kukreti and D. Chattopadhaya et al., 2005. Association of the PIM3 allele of the alpha-1-antitrypsin gene with chronic obstructive pulmonary disease. Clin. Biochem., 38: 489-491.
    CrossRef  |  PubMed  |  Direct Link  |  

  14. Dabur, R., S.K. Diwedi, V. Mishra, V. Yadav, R. Singh and G.L. Sharma, 2005. Efficacy of 2-(3,4-Dimethyl-2,5-Dihydro-1H-Pyrrole-2-yl)-1-methylethyl pentanoate in a murine model of invasive aspergillosis. Antimicrob. Agents Chemother., 49: 4365-4367.
    CrossRef  |  PubMed  |  Direct Link  |  

  15. Dabur, R., A.K. Chhillar, V. Yadav, P.K. Kamal and J. Gupta et al., 2005. In vitro antifungal activity of 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydropyrrole derivative. J. Med. Microbiol., 54: 549-552.
    CrossRef  |  PubMed  |  Direct Link  |  
Member since September, 2015